{"id":490579,"date":"2026-06-13T07:41:18","date_gmt":"2026-06-13T07:41:18","guid":{"rendered":"https:\/\/www.newsbeep.com\/il\/490579\/"},"modified":"2026-06-13T07:41:18","modified_gmt":"2026-06-13T07:41:18","slug":"ascletis-pharma-sehk1672-stock-valuation-after-recent-weak-price-performance","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/il\/490579\/","title":{"rendered":"Ascletis Pharma (SEHK:1672) Stock Valuation After Recent Weak Price Performance"},"content":{"rendered":"\n<p class=\"yf-1fy9kyt\"><a href=\"https:\/\/simplywall.st\/features\/portfolio?utm_medium=finance_user&amp;utm_campaign=updates_head_cta&amp;utm_source=yahoo&amp;blueprint=4623315\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Never miss an important update on your stock portfolio;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Never miss an important update on your stock portfolio&quot;}\" class=\"link \">Never miss an important update on your stock portfolio<\/a> and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.<\/p>\n<p>      What recent price moves say about Ascletis Pharma    <\/p>\n<p class=\"yf-1fy9kyt\">Ascletis Pharma (SEHK:1672) has come under pressure recently, with the stock down 4.4% over the past week and down 41.6% over the past month, drawing attention to its current valuation and fundamentals.<\/p>\n<p class=\"yf-1fy9kyt\"><a href=\"https:\/\/www.simplywall.st\/company\/id\/6774b3ae-e2d9-4900-a73e-6094d9c5283b?utm_medium=finance_user&amp;utm_campaign=cta_company_latest_analysis&amp;utm_source=yahoo\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:See our latest analysis for Ascletis Pharma.;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;See our latest analysis for Ascletis Pharma.&quot;}\" class=\"link \">See our latest analysis for Ascletis Pharma.<\/a><\/p>\n<p class=\"yf-1fy9kyt\">Beyond the past week, the share price has been weak over the last month and quarter, although the 1 year and multi year total shareholder returns remain positive, which suggests earlier investors have still seen meaningful gains.<\/p>\n<p class=\"yf-1fy9kyt\">If you are comparing Ascletis Pharma with other healthcare opportunities, this is a good moment to see how it stacks up against <a href=\"https:\/\/simplywall.st\/discover\/investing-ideas\/434426\/healthcare-ai\/global?utm_medium=finance_user&amp;utm_campaign=cta_screener_healthcare_ai&amp;utm_source=yahoo&amp;blueprint=4623315\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:133 healthcare AI stocks;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;133 healthcare AI stocks&quot;}\" class=\"link \">133 healthcare AI stocks<\/a><\/p>\n<p class=\"yf-1fy9kyt\">With the stock sliding over the past quarter but longer term returns still in positive territory, the key question now is whether Ascletis Pharma is trading below its underlying potential or whether the market is already pricing in future growth.<\/p>\n<p>      Preferred Price to Book of 4.7x: Is it justified?    <\/p>\n<p class=\"yf-1fy9kyt\">On a P\/B basis, Ascletis Pharma trades at 4.7x, which screens as expensive versus the Hong Kong Biotechs industry average of 3.2x, even after the recent share price pullback.<\/p>\n<p class=\"yf-1fy9kyt\">The P\/B ratio compares the market value of the company to its book value. It is often used for businesses that are not yet profitable but have meaningful assets and R&amp;D on the balance sheet. For Ascletis Pharma, this ratio matters because the company is still loss making and reported a negative Return on Equity of 18.61%, so earnings based metrics are less useful right now.<\/p>\n<p class=\"yf-1fy9kyt\">Compared with the broader Hong Kong Biotechs industry, where the average P\/B stands at 3.2x, Ascletis Pharma\u2019s 4.7x suggests investors are currently paying a higher price for each unit of net assets than the sector average. However, against a peer group where the average P\/B is 12.5x, the stock screens as cheaper, which underlines how mixed the valuation signals are depending on which comparison set you use.<\/p>\n<p class=\"yf-1fy9kyt\"><a href=\"https:\/\/www.simplywall.st\/company\/id\/6774b3ae-e2d9-4900-a73e-6094d9c5283b\/valuation?utm_medium=finance_user&amp;utm_campaign=alternate_preferred_multiple_cta&amp;utm_source=yahoo\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:See what the numbers say about this price \u2014 find out in our valuation breakdown.;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;See what the numbers say about this price \u2014 find out in our valuation breakdown.&quot;}\" class=\"link \">See what the numbers say about this price \u2014 find out in our valuation breakdown.<\/a><\/p>\n<p class=\"yf-1fy9kyt\">Result: Price-to-book of 4.7x (ABOUT RIGHT).<\/p>\n<p class=\"yf-1fy9kyt\">However, weakening annual revenue and net income, together with ongoing losses, could quickly change how the recent valuation signals are viewed.<\/p>\n<p class=\"yf-1fy9kyt\"><a href=\"https:\/\/www.simplywall.st\/company\/id\/6774b3ae-e2d9-4900-a73e-6094d9c5283b?utm_medium=finance_user&amp;utm_campaign=risks_narrative_cta&amp;utm_source=yahoo\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Find out about the key risks to this Ascletis Pharma narrative.;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Find out about the key risks to this Ascletis Pharma narrative.&quot;}\" class=\"link \">Find out about the key risks to this Ascletis Pharma narrative.<\/a><\/p>\n<p>      Next Steps     <\/p>\n<p class=\"yf-1fy9kyt\">With sentiment this mixed, it makes sense to check the underlying data yourself and decide how comfortable you are with the current setup. Before making any move, take a closer look at the 2 important warning signs.<\/p>\n<p>       Looking for more investment ideas?   <\/p>\n<p class=\"yf-1fy9kyt\">Before the next move in Ascletis Pharma, broaden your watchlist with other opportunities that fit clear, data driven criteria using the Simply Wall Street Screener.<\/p>\n<p class=\"yf-1fy9kyt\"> This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.<\/p>\n<p class=\"yf-1fy9kyt\">Companies discussed in this article include <a href=\"https:\/\/finance.yahoo.com\/quote\/1672.HK\" data-ylk=\"slk:1672.HK;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;1672.HK&quot;}\" class=\"link \" rel=\"nofollow noopener\" target=\"_blank\">1672.HK<\/a>.<\/p>\n<p class=\"yf-1fy9kyt\">Have feedback on this article? Concerned about the content? <a href=\"https:\/\/investor-research.typeform.com\/to\/wvg6MFri#feedback_token=NDYyMzMxNTo1NTViZTVhMmFjNmNjMmQ1&amp;company=SEHK:1672&amp;blueprintid=4623315\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Get in touch;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Get in touch&quot;}\" class=\"link \">Get in touch<\/a> with us directly. Alternatively, email <a href=\"https:\/\/finance.yahoo.com\/markets\/stocks\/articles\/mailto:editorial-team@simplywallst.com?subject=Re%3A%20Your%20article%20on%20SEHK%3A1672%20(yahoo)%20from%2013th%20June%202026\" data-ylk=\"slk:editorial-team@simplywallst.com;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;editorial-team@simplywallst.com&quot;}\" class=\"link \" rel=\"nofollow noopener\" target=\"_blank\">editorial-team@simplywallst.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors&hellip;\n","protected":false},"author":2,"featured_media":247411,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[226365,114,85,46],"class_list":["post-490579","post","type-post","status-publish","format-standard","has-post-thumbnail","category-business","tag-ascletis-pharma","tag-business","tag-il","tag-israel"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/490579","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=490579"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/490579\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/247411"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=490579"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=490579"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=490579"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}